Skip to main content
Fig. 4 | Journal of Inflammation

Fig. 4

From: Esomeprazole attenuates inflammatory and fibrotic response in lung cells through the MAPK/Nrf2/HO1 pathway

Fig. 4

Western blot data showing phosphorylation of ERK1/2 (pERK1/2), and MEK1/2 (pMEK1/2) in human IPF lung fibroblasts treated with various concentrations of esomeprazole (1–100 μM). Data is representative of at least three independent experiments. Beta actin (ACTB) is used as loading control. Densitometric quantification of the protein bands relative to ACTB is shown in the lower panel. *p < 0.05 vs control

Back to article page

Journal of Inflammation

ISSN: 1476-9255

Contact us